L&C BIO Co.,LTD (KOSDAQ:290650)
South Korea flag South Korea · Delayed Price · Currency is KRW
68,800
+3,300 (5.04%)
At close: Dec 5, 2025

L&C BIO Co.,LTD Revenue

L&C BIO Co.,LTD had revenue of 22.56B KRW in the quarter ending September 30, 2025, with 21.66% growth. This brings the company's revenue in the last twelve months to 79.99B, up 19.41% year-over-year. In the year 2024, L&C BIO Co.,LTD had annual revenue of 72.09B with 9.35% growth.

Revenue (ttm)
79.99B
Revenue Growth
+19.41%
P/S Ratio
21.17
Revenue / Employee
567.32M
Employees
141
Market Cap
1,693.78B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202472.09B6.17B9.35%
Dec 31, 202365.93B13.35B25.40%
Dec 31, 202252.57B6.90B15.10%
Dec 31, 202145.68B12.70B38.53%
Dec 31, 202032.97B3.82B13.11%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Samsung Biologics 5,504.84B
Celltrion 3,895.99B
ALTEOGEN 202.18B
ABL Bio 88.44B
SK Biopharmaceuticals 675.41B
Yuhan 2,136.67B
LigaChem Biosciences 159.27B
Peptron 6.19B
Revenue Rankings